Stock listing

Zymeworks Inc.

Selected listing: ZYME · NASDAQ · USD · US

Zymeworks Inc. (NASDAQ:ZYME), Health Technology. Latest release Sep 28, 2026: Zymeworks Announces Updated 2026 Financial Guidance and Final Transaction…

ZYME:NASDAQUSDUSUpdated September 25, 2026

Ticker: NASDAQ:ZYME
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: NASDAQ
Currency: USD

About Zymeworks Inc.

Zymeworks Inc. is a public biotechnology company listed under the ticker ZYME, operating in the American market. The company focuses on developing innovative therapeutic solutions for cancer and other diseases.

Latest news from Zymeworks Inc.

Zymeworks Announces Updated 2026 Financial Guidance and Final Transaction Details Following Theravance Biopharma Acquisition

September 28, 2026

Zymeworks Completes Acquisition of Theravance Biopharma

September 23, 2026

Zymeworks : Quarterly Report for Quarter Ending June 30, 2026 (Form 10-Q)

August 6, 2026

Zymeworks Provides Corporate Update and Reports Second Quarter 2026 Financial Results

August 6, 2026

Zymeworks to Report Second Quarter 2026 Financial Results on August 6, 2026

July 16, 2026

All Zymeworks Inc. news →

Events

Replays

Zymeworks Inc. (ZYME) Q1 2026 Earnings Call
Thu, May 07, 2026 · 04:30 PM ET
Watch
Zymeworks Inc. (ZYME) Q4 2025 Earnings Call
Mon, Mar 02, 2026 · 08:30 AM ET
Watch
Zymeworks Inc. (ZYME) Q3 2025 Earnings Call
Thu, Nov 06, 2025 · 04:30 PM ET
Watch

Research Zymeworks Inc.

Zymeworks Inc. company profile

View the public company page for Zymeworks Inc. on 6ix.

Zymeworks Inc. news

Read company news and market updates connected to Zymeworks Inc..

Zymeworks Inc. investor events

Find investor webinars, events, and replay context for Zymeworks Inc..